|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
HEALTH POLICY AND ETHICS |
At the time of this study, Ryan J. Deibert was in the MPH program in the Health Services Department, School of Public Health and Community Medicine, University of Washington, Seattle. Gary Gold-baum and Hanne Thiede are with the Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, and with Department of Public HealthSeattleKing County, Seattle. At the time of this study, Theodore Parker was with Public HealthSeattleKing County, Seattle. Holly Hagan is with the Center for Drug Use and HIV Research, National Development and Research Institutes, New York, NY. Robert Marks and Michael Hanrahan are with Public HealthSeattleKing County, Seattle.
Correspondence: Requests for reprints should be sent to Ryan J. Deibert, Oregon Department of Human Services, 800 NE Oregon St., Suite 1105, Portland, OR 97232 (e-mail: ryan.j.deibert{at}state.or.us).
ABSTRACT
We examined pharmacists attitudes and practices related to syringe sales to injection drug users before and after legal reform and local programming to enhance sterile syringe access. We replicated a 1996 study by conducting pharmacist phone surveys and syringe test-buys in randomly selected pharmacies.
Test-buy success increased from 48% in 1996 to 65% in 2003 (P=.04). Pharmacists agreeing that syringes should be available to injection drug users through pharmacy purchase increased from 49% to 71% (P<.01). Pharmacy policies and pharmacist attitudes were strongly associated with syringe access. Structural changes, including policy reform and pharmacy outreach, appear to increase syringe access. Interventions should address pharmacy policies and pharmacist attitudes and policies.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |